Who has invested in AlloVir?

Fidelity Investments are named among the investors backing AlloVir.

AlloVir Funding: $427M Raised, IPO (2020)

AlloVir funding overview

AlloVir is based in San Francisco, California. AlloVir has raised $427M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in August 2020. The round record for AlloVir runs through 2020; nothing later has been disclosed. Investors on record include Fidelity Investments.

AlloVir at a glance

Total raised: $427M
Latest round: IPO
Latest round date: August 2020
Headquarters: San Francisco, California
Notable investors: Fidelity Investments

Frequently asked about AlloVir funding

How much has AlloVir raised?: AlloVir has raised $427M in total disclosed funding across the rounds on record.
Who has invested in AlloVir?: Fidelity Investments are named among the investors backing AlloVir.
What was the latest AlloVir funding round?: The most recent disclosed round is an IPO, announced in August 2020.
Where is AlloVir based?: AlloVir is based in San Francisco, California.
When did AlloVir last raise?: The last disclosed AlloVir round closed in August 2020 at IPO.

Round data for AlloVir is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Francisco and backer lists below.

AlloVir Funding: $427M Raised, IPO (2020)

AlloVir funding overview

AlloVir at a glance

Frequently asked about AlloVir funding

Companies related to AlloVir (36)

Browse related funding lists (6)